A novel p.T139M mutation in HSPB1 highlighting the phenotypic spectrum in a family

作者：Amornvit Jakkrit; Yalvac Mehmet E; Chen Lei; Sahenk Zarife^*

来源：Brain and Behavior, 2017, 7(8): e00774.

DOI：10.1002/brb3.774

• alpha-crystallin domain
• Charcot-Marie-Tooth disease 2F clinical phenotype
• congophilic aggregates
• HSPB1 mutations

Introduction: Mutations in the HSPB1 gene encoding the small heat shock protein B1 are associated with an autosomal dominant, axonal form of Charcot-Marie-Tooth disease 2F (CMT2F) and distal hereditary motor neuropathy. Recently, distal myopathy had been described in a patient carrying HSPB1 mutation adding to the complexity of phenotypes resulting from HSPB1 mutations.
Methods: Five patients in a family with concerns of hereditary neuropathy were included. Detailed clinical examinations, including assessments of motor and sensory function, and electrophysiological data were obtained. Genetic analysis was requested through a commercial laboratory. In vitro studies were carried out to assess the pathogenicity of the novel mutation found in this family studies.
Results: All patients carried a novel mutation, c. 146 C> T (p. T139M), substitution in the alpha-crystallin domain of HSPB1 causing a clinical phenotype with hyperreflexia and intrafamilial variability, from muscle cramps as the only presenting symptom to a classic CMT phenotype. In vitro studies showed that cells expressing HSPB1-T139M displayed decreased cell viability with increased expression of apoptosis markers. Moreover, overexpression of the mutant, not the wild-type HSPB1, caused formation of congophilic aggregates.
Conclusions: In vitro findings strongly support the pathogenicity of this novel mutation. We propose that Congo red histochemical stain may serve as a simple screening tool for investigating if the aggregates in mutant cells have misfolded beta-pleated sheet secondary structures.